US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 2.940
  • +0.100+3.52%
Close May 9 16:00 ET
  • 3.000
  • +0.060+2.04%
Pre 08:15 ET
554.83MMarket Cap-6681P/E (TTM)

Arbutus Biopharma Key Stats

Arbutus Biopharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

1.53M

-77.09%
EPS(YoY)

-0.10

0.00%

Buy

Apr 30, 2024

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.313M--
--2024/Q2-- / 2.411M--
May 2, 20242024/Q12.108M / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--
Nov 7, 20232023/Q36.370M / 6.405M--
Aug 3, 20232023/Q26.202M / 8.292M--
May 4, 20232023/Q19.107M / 8.234M--
Mar 2, 20232022/Q48.502M / 8.312M--
Nov 9, 20222022/Q38.009M / 12.395M--
Aug 4, 20222022/Q218.308M / 8.713M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.313M--
--2024/Q2-- / 2.411M--
May 2, 20242024/Q12.108M / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--
Nov 7, 20232023/Q36.370M / 6.405M--
Aug 3, 20232023/Q26.202M / 8.292M--
May 4, 20232023/Q19.107M / 8.234M--
Mar 2, 20232022/Q48.502M / 8.312M--
Nov 9, 20222022/Q38.009M / 12.395M--
Aug 4, 20222022/Q218.308M / 8.713M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg